Investigation of Delafloxacin Resistance in Multidrug-Resistant Escherichia coli Strains and the Detection of E. coli ST43 International High-Risk Clone

Delafloxacin is a novel fluoroquinolone agent that is approved for clinical application. In this study, we analyzed the antibacterial efficacy of delafloxacin in a collection of 47 Escherichia coli strains. Antimicrobial susceptibility testing was performed by the broth microdilution method and mini...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulyás, Dániel, Kamotsay, Katalin, Szabó, Dóra, Kocsis, Béla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301206/
https://www.ncbi.nlm.nih.gov/pubmed/37375104
http://dx.doi.org/10.3390/microorganisms11061602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301206/
https://www.ncbi.nlm.nih.gov/pubmed/37375104
http://dx.doi.org/10.3390/microorganisms11061602

Ejemplares similares